✦ LIBER ✦

230: Cardiovascular Events and Mortality in Chronic Kidney Disease Patients Treated With Epoetin Alfa or Darbepoetin Alfa

✍ Scribed by Erdal Sarac; Victor Lossev; Donald J. Misquitta; Ali Dinani; David Gemmel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose Conversion from Epoetin alfa to Dar

✍ Arnold I. Barnett; Pierre Y. Crémieux 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

PUK21 Conversion From Epoetin Alfa to Da

✍ R. Binaut; J.L. Bacri; D. Fleury; N. Maisonneuve; D. Labatut; V. Lemaitre; Z. Me 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

CS1 EPOETIN ALFA AND DARBEPOETIN ALFA DO

✍ S Mody; V Padmanabhan; B Bookhart; RS Mckenzie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PSY23 ECONOMIC EVALUATION OF DARBEPOETIN

✍ P Vorobiev; M Lesnicheva; M Avksentieva; N Nekrasova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Managing Anemia in Patients with Chronic

✍ Shane D. Scott 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

133: Hematologic Outcomes and Dosing Pat

✍ Claudia Hura; James Jackson; Orsolya Lunacsek; Robert A. Bailey; R. Scott McKenz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB